Breasts: Plastic Surgery

(asked on 5th January 2022) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what plans they have to strengthen warnings on breast implants in light of reports of increasing numbers of cases of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).


Answered by
Lord Kamall Portrait
Lord Kamall
This question was answered on 24th January 2022

For breast implants and other implantable materials, the Medicines and Healthcare products Regulatory Agency (MHRA) is currently considering what information should be provided to the patient at the point of consent and on receipt of the implant. The new regulatory approach is not yet finalised but warnings, precautions or measures to be taken by the patient or a healthcare professional are being considered as is a caution that risk may emerge during use of an implantable device, including, where appropriate, on Breast Implant Associated Anaplastic Large Cell Lymphoma. Further information about the outcome of the public consultation on the regulation of medical devices is expected to be published early this year.

Reticulating Splines